Twenty All India Institute of Medical Sciences (AIIMS) institutions across the country have signed a Memorandum of Understanding (MoU) to establish a pan‑India collaborative research consortium, marking a significant step in strengthening the nation’s biomedical and clinical research ecosystem.
The MoU was executed during AIIMS Research Day 2026 in New Delhi, where directors and senior officials from all participating AIIMS campuses formalised the pact to work together on joint research projects, multi‑institutional studies and clinical trials.
The framework aims to promote systematic exchange of researchers, harmonise research protocols and share best practices across the network.
The consortium spans AIIMS campuses in New Delhi, Bathinda, Bhopal, Bhubaneswar, Bibinagar, Bilaspur, Deoghar, Gorakhpur, Guwahati, Jammu, Jodhpur, Kalyani, Madurai, Mangalagiri, Nagpur, Patna, Raebareli, Raipur, Rajkot and Rishikesh, leveraging their combined expertise, infrastructure and patient base to address priority health challenges at national scale.
Officials at the meeting discussed setting national research priorities and accelerating large‑scale clinical trials. Emerging focus areas include artificial intelligence in healthcare, affordable cancer therapies, prevention and control of healthcare‑associated infections, and metabolic disorders. To ensure coordinated action, the agreement provides for the nomination of nodal officers and single points of contact at each institution.
The consortium is expected to strengthen research capacity across India’s premier medical institutes, improve the quality and reproducibility of scientific evidence, and accelerate the translation of research findings into effective healthcare solutions and evidence‑based policy interventions.
Also Read